FdaApplication
NDA 021759
Identifiers
- fda_app_no: NDA021759
Properties
| Property | Value |
|---|---|
| applicant_name | SANOFI AVENTIS US LLC |
| application_type | NDA |
| approval_date | 2005-01-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELOXATIN | OXALIPLATIN | 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| ELOXATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| ELOXATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
3 products